| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:737506 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MAT2A mRNA | CTD | PMID:22079256 |
| 1,2,4-trimethylbenzene | increases expression | EXP | | 6480464 | pseudocumene results in increased expression of MAT2A protein | CTD | PMID:17337753 |
| 17beta-estradiol | increases expression | ISO | RGD:737506 | 6480464 | Estradiol results in increased expression of MAT2A mRNA | CTD | PMID:19167446 PMID:23019147 |
| 17beta-estradiol | increases expression | ISO | RGD:737506 | 6480464 | Estradiol results in increased expression of MAT2A mRNA | CTD | PMID:23019147 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:732781 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MAT2A mRNA | CTD | PMID:19465110 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:732781 | 6480464 | Tetrachlorodibenzodioxin affects the expression of MAT2A mRNA | CTD | PMID:21570461 |
| 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in decreased expression of MAT2A mRNA | CTD | PMID:19162173 |
| 4-phenylbutyric acid | decreases expression | ISO | RGD:737506 | 6480464 | 4-phenylbutyric acid results in decreased expression of MAT2A mRNA | CTD | PMID:14583596 |
| 7,12-dimethyltetraphene | affects expression | ISO | RGD:732781 | 6480464 | 9,10-Dimethyl-1,2-benzanthracene affects the expression of MAT2A mRNA | CTD | PMID:21785161 |
| acetaldehyde | decreases expression | ISO | RGD:737506 | 6480464 | Acetaldehyde results in decreased expression of MAT2A mRNA | CTD | PMID:23416264 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:737506 | 6480464 | Tretinoin results in decreased expression of MAT2A mRNA | CTD | PMID:15498508 |
| arsenic atom | affects expression | ISO | RGD:737506 | 6480464 | Arsenic affects the expression of MAT2A mRNA | CTD | PMID:18487201 |
| benzene | increases expression | ISO | RGD:737506 | 6480464 | Benzene results in increased expression of MAT2A mRNA | CTD | PMID:19162166 |
| benzo[a]pyrene | increases expression | ISO | RGD:737506 | 6480464 | Benzo(a)pyrene results in increased expression of MAT2A mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | affects expression | ISO | RGD:732781 | 6480464 | Benzo(a)pyrene affects the expression of MAT2A mRNA | CTD | PMID:22342234 |
| benzo[a]pyrene | increases expression | ISO | RGD:732781 | 6480464 | Benzo(a)pyrene results in increased expression of MAT2A mRNA | CTD | PMID:21569818 PMID:22228805 |
| benzo[a]pyrene | increases expression | ISO | RGD:732781 | 6480464 | Benzo(a)pyrene results in increased expression of MAT2A mRNA | CTD | PMID:21569818 |
| benzo[a]pyrene | decreases expression | ISO | RGD:732781 | 6480464 | Benzo(a)pyrene results in decreased expression of MAT2A mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:732781 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of MAT2A mRNA | CTD | PMID:21715664 |
| bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of MAT2A promoter | CTD | PMID:23359474 |
| bisphenol A | decreases expression | ISO | RGD:732781 | 6480464 | bisphenol A results in decreased expression of MAT2A mRNA | CTD | PMID:21932408 |
| bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of MAT2A promoter | CTD | PMID:23359474 |
| cadmium sulfate | decreases expression | ISO | RGD:737506 | 6480464 | cadmium sulfate results in decreased expression of MAT2A mRNA | CTD | PMID:21783983 |
| cadmium sulfate | decreases expression | ISO | RGD:737506 | 6480464 | cadmium sulfate results in decreased expression of MAT2A mRNA | CTD | PMID:12064557 PMID:21783983 |
| cadmium sulfate | decreases expression | ISO | RGD:737506 | 6480464 | cadmium sulfate results in decreased expression of MAT2A mRNA | CTD | PMID:21783983 PMID:12064557 |
| chloroprene | increases expression | EXP | | 6480464 | Chloroprene results in increased expression of MAT2A mRNA | CTD | PMID:23125180 |
| chloroprene | increases expression | ISO | RGD:732781 | 6480464 | Chloroprene results in increased expression of MAT2A mRNA | CTD | PMID:23125180 |
| choline | multiple interactions | ISO | RGD:732781 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAT2A mRNA | CTD | PMID:20938992 |
| clofibrate | decreases expression | ISO | RGD:732781 | 6480464 | Clofibrate results in decreased expression of MAT2A mRNA | CTD | PMID:17585979 |
| cobalt dichloride | decreases expression | ISO | RGD:737506 | 6480464 | cobaltous chloride results in decreased expression of MAT2A mRNA | CTD | PMID:19320972 |
| cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of MAT2A mRNA | CTD | PMID:20187946 |
| copper atom | decreases expression | EXP | | 6480464 | Copper results in decreased expression of MAT2A mRNA | CTD | PMID:22465980 |
| copper(0) | decreases expression | EXP | | 6480464 | Copper results in decreased expression of MAT2A mRNA | CTD | PMID:22465980 |
| copper(2+) sulfate | increases expression | ISO | RGD:737506 | 6480464 | Copper Sulfate results in increased expression of MAT2A mRNA | CTD | PMID:19549813 |
| Delta(9)-tetrahydrocannabinol | decreases expression | ISO | RGD:732781 | 6480464 | Tetrahydrocannabinol results in decreased expression of MAT2A mRNA | CTD | PMID:12237329 |
| dibutyl phthalate | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of MAT2A promoter | CTD | PMID:23359474 |
| dimethyl sulfoxide | increases activity | ISO | RGD:732781 | 6480464 | Dimethyl Sulfoxide results in increased activity of MAT2A protein | CTD | PMID:8373829 |
| ethanol | decreases expression | ISO | RGD:737506 | 6480464 | Ethanol results in decreased expression of MAT2A mRNA | CTD | PMID:17869084 |
| fenofibrate | decreases expression | ISO | RGD:737506 | 6480464 | Fenofibrate results in decreased expression of MAT2A mRNA | CTD | PMID:16569247 |
| folic acid | multiple interactions | ISO | RGD:732781 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAT2A mRNA | CTD | PMID:20938992 |
| formaldehyde | decreases expression | ISO | RGD:737506 | 6480464 | Formaldehyde results in decreased expression of MAT2A mRNA | CTD | PMID:20655997 |
| hydrogen peroxide | affects expression | ISO | RGD:737506 | 6480464 | Hydrogen Peroxide affects the expression of MAT2A mRNA | CTD | PMID:20044591 |
| L-methionine | multiple interactions | ISO | RGD:732781 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAT2A mRNA | CTD | PMID:20938992 |
| lead diacetate | decreases expression | ISO | RGD:732781 | 6480464 | lead acetate results in decreased expression of MAT2A mRNA | CTD | PMID:21829687 |
| menadione | affects expression | ISO | RGD:737506 | 6480464 | Vitamin K 3 affects the expression of MAT2A mRNA | CTD | PMID:20044591 |
| nickel dichloride | decreases expression | ISO | RGD:737506 | 6480464 | nickel chloride results in decreased expression of MAT2A mRNA | CTD | PMID:17312168 |
| paracetamol | affects expression | ISO | RGD:732781 | 6480464 | Acetaminophen affects the expression of MAT2A mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of MAT2A mRNA | CTD | PMID:19103213 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of MAT2A mRNA | CTD | PMID:19162173 |
| phenobarbital | multiple interactions | ISO | RGD:732781 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of MAT2A mRNA] | CTD | PMID:19482888 |
| phenobarbital | increases expression | ISO | RGD:732781 | 6480464 | Phenobarbital results in increased expression of MAT2A mRNA | CTD | PMID:19482888 |
| pirinixic acid | multiple interactions | ISO | RGD:737506 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MAT2A mRNA | CTD | PMID:19710929 |
| pirinixic acid | increases expression | ISO | RGD:732781 | 6480464 | pirinixic acid results in increased expression of MAT2A mRNA | CTD | PMID:17950772 more ... |
| pirinixic acid | increases expression | ISO | RGD:732781 | 6480464 | pirinixic acid results in increased expression of MAT2A mRNA | CTD | PMID:18301758 more ... |
| pirinixic acid | increases expression | ISO | RGD:732781 | 6480464 | pirinixic acid results in increased expression of MAT2A mRNA | CTD | PMID:18445702 more ... |
| pirinixic acid | multiple interactions | ISO | RGD:732781 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in increased expression of MAT2A mRNA] | CTD | PMID:17950772 |
| pirinixic acid | increases expression | ISO | RGD:732781 | 6480464 | pirinixic acid results in increased expression of MAT2A mRNA | CTD | PMID:17950772 more ... |
| progesterone | decreases expression | ISO | RGD:737506 | 6480464 | Progesterone results in decreased expression of MAT2A mRNA | CTD | PMID:18037150 |
| quinomethionate | affects expression | ISO | RGD:737506 | 6480464 | quinomethionate affects the expression of MAT2A mRNA | CTD | PMID:15387888 |
| resveratrol | increases expression | ISO | RGD:737506 | 6480464 | resveratrol results in increased expression of MAT2A mRNA | CTD | PMID:19167446 |
| S-adenosyl-L-methionine | increases chemical synthesis | ISO | RGD:732781 | 6480464 | MAT2A protein results in increased chemical synthesis of S-Adenosylmethionine | CTD | PMID:8373829 |
| tamibarotene | decreases expression | ISO | RGD:737506 | 6480464 | Am 80 results in decreased expression of MAT2A mRNA; more ... | CTD | PMID:15498508 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of MAT2A mRNA | CTD | PMID:17485851 |
| thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of MAT2A mRNA; more ... | CTD | PMID:10216131 |
| trans-resveratrol | increases expression | ISO | RGD:737506 | 6480464 | resveratrol results in increased expression of MAT2A mRNA | CTD | PMID:19167446 |
| valproic acid | affects expression | ISO | RGD:732781 | 6480464 | Valproic Acid affects the expression of MAT2A mRNA | CTD | PMID:17292431 PMID:17963808 |
| valproic acid | decreases expression | ISO | RGD:732781 | 6480464 | Valproic Acid results in decreased expression of MAT2A mRNA | CTD | PMID:21427059 |
| valproic acid | affects expression | ISO | RGD:732781 | 6480464 | Valproic Acid affects the expression of MAT2A mRNA | CTD | PMID:17963808 PMID:17292431 |
| valproic acid | decreases expression | ISO | RGD:732781 | 6480464 | Valproic Acid results in decreased expression of MAT2A mRNA | CTD | PMID:21427059 PMID:20546886 |
| valproic acid | decreases expression | ISO | RGD:732781 | 6480464 | Valproic Acid results in decreased expression of MAT2A mRNA | CTD | PMID:20546886 PMID:21427059 |
| zinc atom | multiple interactions | ISO | RGD:737506 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of MAT2A mRNA | CTD | PMID:18593933 |
| zinc(0) | multiple interactions | ISO | RGD:737506 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of MAT2A mRNA | CTD | PMID:18593933 |